WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> Access To Medicines Foundation Details Methodology For 2018 AMR Benchmark 24/08/2017 William New The Amsterdam-based Access to Medicines Foundation today published the methodology it will use for its 2018 framework for evaluating how pharmaceutical companies are taking action to limit antimicrobial resistance, addressing the rising the global problem of overuse of antibiotics leading to resistance with few new ones in the pipeline. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> G20: Security, Trade, Climate, Trump Diplomacy Overshadow Health, IT, Innovation 07/07/2017 Monika Ermert On the eve of the G20 meeting in Hamburg, Germany, German politicians described positions on free trade and climate as the most difficult issues. Expectations from civil society groups in the G20 results are modest at best and the 6 July protest march “Welcome to Hell” was cancelled after clashes between the police and parts of the protestors. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version 29/06/2017 Fredrick Nzwili NAIROBI, Kenya - A generic version of dolutegravir (DTG), the drug of choice for the last two years for people living with HIV in high-income countries, is now available in Africa. On 28 June, the government of Kenya and drug pricing and innovation mechanism Unitaid unveiled the new first-line drug in an effort to accelerate access to better antiretroviral (ARV) drugs for her people living with HIV. It becomes the first country in Africa to introduce the generic version of drug. Continue reading -> Polypills: Are Miracle Treatments Being Overlooked? 05/06/2017 Tatum Anderson Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Continue reading -> Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say 19/05/2017 Elise De Geyter Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading -> G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Access To Medicines Foundation Details Methodology For 2018 AMR Benchmark 24/08/2017 William New The Amsterdam-based Access to Medicines Foundation today published the methodology it will use for its 2018 framework for evaluating how pharmaceutical companies are taking action to limit antimicrobial resistance, addressing the rising the global problem of overuse of antibiotics leading to resistance with few new ones in the pipeline. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> G20: Security, Trade, Climate, Trump Diplomacy Overshadow Health, IT, Innovation 07/07/2017 Monika Ermert On the eve of the G20 meeting in Hamburg, Germany, German politicians described positions on free trade and climate as the most difficult issues. Expectations from civil society groups in the G20 results are modest at best and the 6 July protest march “Welcome to Hell” was cancelled after clashes between the police and parts of the protestors. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version 29/06/2017 Fredrick Nzwili NAIROBI, Kenya - A generic version of dolutegravir (DTG), the drug of choice for the last two years for people living with HIV in high-income countries, is now available in Africa. On 28 June, the government of Kenya and drug pricing and innovation mechanism Unitaid unveiled the new first-line drug in an effort to accelerate access to better antiretroviral (ARV) drugs for her people living with HIV. It becomes the first country in Africa to introduce the generic version of drug. Continue reading -> Polypills: Are Miracle Treatments Being Overlooked? 05/06/2017 Tatum Anderson Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Continue reading -> Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say 19/05/2017 Elise De Geyter Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading -> G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> G20: Security, Trade, Climate, Trump Diplomacy Overshadow Health, IT, Innovation 07/07/2017 Monika Ermert On the eve of the G20 meeting in Hamburg, Germany, German politicians described positions on free trade and climate as the most difficult issues. Expectations from civil society groups in the G20 results are modest at best and the 6 July protest march “Welcome to Hell” was cancelled after clashes between the police and parts of the protestors. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version 29/06/2017 Fredrick Nzwili NAIROBI, Kenya - A generic version of dolutegravir (DTG), the drug of choice for the last two years for people living with HIV in high-income countries, is now available in Africa. On 28 June, the government of Kenya and drug pricing and innovation mechanism Unitaid unveiled the new first-line drug in an effort to accelerate access to better antiretroviral (ARV) drugs for her people living with HIV. It becomes the first country in Africa to introduce the generic version of drug. Continue reading -> Polypills: Are Miracle Treatments Being Overlooked? 05/06/2017 Tatum Anderson Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Continue reading -> Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say 19/05/2017 Elise De Geyter Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading -> G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> G20: Security, Trade, Climate, Trump Diplomacy Overshadow Health, IT, Innovation 07/07/2017 Monika Ermert On the eve of the G20 meeting in Hamburg, Germany, German politicians described positions on free trade and climate as the most difficult issues. Expectations from civil society groups in the G20 results are modest at best and the 6 July protest march “Welcome to Hell” was cancelled after clashes between the police and parts of the protestors. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version 29/06/2017 Fredrick Nzwili NAIROBI, Kenya - A generic version of dolutegravir (DTG), the drug of choice for the last two years for people living with HIV in high-income countries, is now available in Africa. On 28 June, the government of Kenya and drug pricing and innovation mechanism Unitaid unveiled the new first-line drug in an effort to accelerate access to better antiretroviral (ARV) drugs for her people living with HIV. It becomes the first country in Africa to introduce the generic version of drug. Continue reading -> Polypills: Are Miracle Treatments Being Overlooked? 05/06/2017 Tatum Anderson Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Continue reading -> Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say 19/05/2017 Elise De Geyter Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading -> G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
G20: Security, Trade, Climate, Trump Diplomacy Overshadow Health, IT, Innovation 07/07/2017 Monika Ermert On the eve of the G20 meeting in Hamburg, Germany, German politicians described positions on free trade and climate as the most difficult issues. Expectations from civil society groups in the G20 results are modest at best and the 6 July protest march “Welcome to Hell” was cancelled after clashes between the police and parts of the protestors. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version 29/06/2017 Fredrick Nzwili NAIROBI, Kenya - A generic version of dolutegravir (DTG), the drug of choice for the last two years for people living with HIV in high-income countries, is now available in Africa. On 28 June, the government of Kenya and drug pricing and innovation mechanism Unitaid unveiled the new first-line drug in an effort to accelerate access to better antiretroviral (ARV) drugs for her people living with HIV. It becomes the first country in Africa to introduce the generic version of drug. Continue reading -> Polypills: Are Miracle Treatments Being Overlooked? 05/06/2017 Tatum Anderson Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Continue reading -> Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say 19/05/2017 Elise De Geyter Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading -> G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version 29/06/2017 Fredrick Nzwili NAIROBI, Kenya - A generic version of dolutegravir (DTG), the drug of choice for the last two years for people living with HIV in high-income countries, is now available in Africa. On 28 June, the government of Kenya and drug pricing and innovation mechanism Unitaid unveiled the new first-line drug in an effort to accelerate access to better antiretroviral (ARV) drugs for her people living with HIV. It becomes the first country in Africa to introduce the generic version of drug. Continue reading -> Polypills: Are Miracle Treatments Being Overlooked? 05/06/2017 Tatum Anderson Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Continue reading -> Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say 19/05/2017 Elise De Geyter Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading -> G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version 29/06/2017 Fredrick Nzwili NAIROBI, Kenya - A generic version of dolutegravir (DTG), the drug of choice for the last two years for people living with HIV in high-income countries, is now available in Africa. On 28 June, the government of Kenya and drug pricing and innovation mechanism Unitaid unveiled the new first-line drug in an effort to accelerate access to better antiretroviral (ARV) drugs for her people living with HIV. It becomes the first country in Africa to introduce the generic version of drug. Continue reading -> Polypills: Are Miracle Treatments Being Overlooked? 05/06/2017 Tatum Anderson Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Continue reading -> Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say 19/05/2017 Elise De Geyter Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading -> G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Polypills: Are Miracle Treatments Being Overlooked? 05/06/2017 Tatum Anderson Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Continue reading -> Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say 19/05/2017 Elise De Geyter Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading -> G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say 19/05/2017 Elise De Geyter Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading -> G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting 18/05/2017 Monika Ermert Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading -> Posts navigation Older postsNewer posts